Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cantonetti

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1988
[Current aspects of treatment of multiple myeloma]M Tribalto, G Avvisati, M Cantonetti, et al.
Haematologica|September 1, 1991
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patientsM Tribalto, M Cantonetti, G Catalano, et al.
Leukemia Research|January 1, 1985
Treatment of multiple myeloma: a randomized study of three different regimensM Tribalto, S Amadori, M Cantonetti, et al.
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patientsM Boccadoro, F Marmont, M Tribalto, et al.
Cancer Genetics and Cytogenetics|October 1, 1995
Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapyM C Cox-Froncillo, M Cantonetti, M Masi, et al.
Anticancer Research|March 2, 2005
Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapyA P Anselmo, E Cavalieri, F M Osti, et al.
Case Reports in Hematology|October 16, 2019
The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell LymphomaR Palmieri, F Esposito, F Meconi, et al.
Bone Marrow Transplantation|October 14, 2008
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusionL Cudillo, R Cerretti, G Baliva, et al.
Cancer Treatment Reviews|January 1, 1988
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocolF Mandelli, M Tribalto, G Avvisati, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1988
[Current aspects of treatment of multiple myeloma]M Tribalto, G Avvisati, M Cantonetti, et al.
Haematologica|September 1, 1991
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patientsM Tribalto, M Cantonetti, G Catalano, et al.
Leukemia Research|January 1, 1985
Treatment of multiple myeloma: a randomized study of three different regimensM Tribalto, S Amadori, M Cantonetti, et al.
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patientsM Boccadoro, F Marmont, M Tribalto, et al.
Cancer Genetics and Cytogenetics|October 1, 1995
Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapyM C Cox-Froncillo, M Cantonetti, M Masi, et al.
Anticancer Research|March 2, 2005
Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapyA P Anselmo, E Cavalieri, F M Osti, et al.
Case Reports in Hematology|October 16, 2019
The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell LymphomaR Palmieri, F Esposito, F Meconi, et al.
Bone Marrow Transplantation|October 14, 2008
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusionL Cudillo, R Cerretti, G Baliva, et al.
Cancer Treatment Reviews|January 1, 1988
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocolF Mandelli, M Tribalto, G Avvisati, et al.
Pageof 4